Skip to main content

Table 2 Baseline clinical, anthropometry and biochemical characteristics of the study participants according to phenotype obesity (n = 9,762)

From: Metabolic obesity phenotypes and chronic kidney disease: a cross-sectional study from the RaNCD cohort study

Characteristic

Metabolically healthy

Metabolically unhealthy

P value *

MHNO (n = 4,717)

MHO (n = 1,302)

MUNO (n = 2,438)

MUO (n = 1,305)

Mean ± SD / n (%)

Age (year)

46.16 ± 8.21

45.70 ± 7.44

49.68 ± 8.41

48.76 ± 7.78

 < 0.001

Sex:

Male

2584 (54.97)

345 (7.34)

1334 (28.38)

438 (9.32)

 < 0.001

Female

2133 (42.15)

957 (18.91)

1104 (21.81)

867 (17.13)

SES:

Low

1594 (33.81)

404 (31.03)

786 (32.27)

438 (33.56)

0.012

Moderate

1541 (32.68)

455 (34.95)

792 (32.51)

477 (36.55)

High

1580 (33.51)

443 (34.02)

858 (35.22)

390 (29.89)

PA:

Low

1263 (26.78)

398 (30.57)

823 (33.76)

472 (36.17)

 < 0.001

Moderate

2137 (45.30)

703 (53.99)

1118 (45.86)

666 (51.03)

High

1317 (27.92)

201 (15.44)

497 (20.39)

167 (12.80)

Current smoker

651 (13.87)

65 (5.01)

325 (13.40)

97 (7.48)

 < 0.001

Alcohol use

249 (5.28)

36 (2.76)

142 (5.82)

51 (3.91)

 < 0.001

Dyslipidemia

1186 (25.14)

323 (24.81)

1912 (78.42)

911 (69.81)

 < 0.001

T2DM

84 (1.780)

34 (2.61)

445 (18.25)

282 (21.61)

 < 0.001

CVD

298 (6.32)

131 (10.06)

755 (30.97)

474 (36.32)

 < 0.001

Hypertension

263 (5.58)

76 (5.84)

739 (30.31)

464 (35.56)

 < 0.001

Kidney stone

830 (17.60)

212 (16.28)

485 (19.89)

262 (20.08)

0.007

BMI (kg/m2)

24.83 ± 3.15

33.10 ± 3.02

26.45 ± 2.41

33.38 ± 3.27

 < 0.001

WHR

0.91 ± 0.05

0.99 ± 0.05

0.94 ± 0.05

0.99 ± 0.06

 < 0.001

Muscle strength (kg)

32.49 ± 11.30

30.24 ± 11.01

31.95 ± 11.52

30.30 ± 10.83

 < 0.001

BFM (kg)

19.87 ± 6.64

36.47 ± 6.77

22.80 ± 5.34

36.55 ± 7.39

 < 0.001

FFM (kg)

46.87 ± 9.20

48.53 ± 9.29

48.23 ± 9.44

50.17 ± 10.22

 < 0.001

BUN (mg/dl)

13.77 ± 4.10

12.83 ± 3.91

14.00 ± 4.5

13.15 ± 4.12

 < 0.001

Cr (mg/dl)

1.00 ± 0.21

0.94 ± 0.17

1.02 ± 0.26

0.98 ± 0.19

 < 0.001

eGFR (ml/min per 1.73 m2)

77.40 ± 14.01

76.44 ± 13.38

74.97 ± 14.13

73.88 ± 13.83

 < 0.001

AST (mg/dl)

21.32 ± 8.90

20.80 ± 11.10

21.84 ± 8.34

21.58 ± 8.66

0.006

ALT (mg/dl)

23.10 ± 13.46

24.91 ± 16.40

27.11 ± 15.50

27.46 ± 15.33

 < 0.001

GGT (mg/dl)

21.79 ± 17.35

23.92 ± 18.75

28.59 ± 23.16

28.92 ± 20.85

 < 0.001

Energy intake (Kcal/day)

2684.44 ± 658.51

2672.25 ± 947.10

2589.10 ± 945.34

26.30 ± 955.28

 < 0.001

Carbohydrate (%E)

61.37 ± 0.10

61.22 ± 0.17

61.34 ± 0.12

61.59 ± 0.17

0.534

Protein (%E)

13.67 ± 0.03

13.53 ± 0.06

14.04 ± 0.04

13.92 ± 0.06

 < 0.001

Lipid (%E)

26.84 ± 0.10

27.42 ± 0.16

26.56 ± 0.12

26.60 ± 0.16

0.002

Sodium intake (g/day)

4.81 ± 0.01

4.97 ± 0.04

4.89 ± 0.03

4.93 ± 0.04

0.008

  1. Abbreviation: MHNO Metabolically healthy non-obese, MHO Metabolically healthy obese, MUNO Metabolically unhealthy non-obese, MUO Metabolically unhealthy obese, BMI Body mass index, PA Physical activity, ALT Alanine aminotransferase, AST Aspartate aminotransferase, CVD Cardiovascular disease, BUN Blood urea nitrogen, Cr Creatinine, GFR Glomerular filtration rate, GGT Gamma-glutamyl transferase, WHR Waist hip ratio, SES socioeconomic status, FFM Fat free mass, BFM Body fat mass
  2. *P-values were obtained one-way ANOVA and Chi square